Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Merck
Boehringer Ingelheim
Moodys
AstraZeneca

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Drug Price Trends for NDC 17478-0715

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Average Pharmacy Cost for 17478-0715

Drug Name NDC Price/Unit ($) Unit Date
BRIMONIDINE 0.2% EYE DROP 17478-0715-12 0.64928 ML 2019-12-18
BRIMONIDINE 0.2% EYE DROP 17478-0715-10 0.96852 ML 2019-12-18
BRIMONIDINE 0.2% EYE DROP 17478-0715-11 0.80578 ML 2019-12-18
BRIMONIDINE 0.2% EYE DROP 17478-0715-12 0.83529 ML 2019-11-20
BRIMONIDINE 0.2% EYE DROP 17478-0715-10 0.92820 ML 2019-11-20
BRIMONIDINE 0.2% EYE DROP 17478-0715-11 0.87348 ML 2019-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 17478-0715

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
BRIMONIDINE TARTRATE 0.2% SOLN,OPH 5ML Golden State Medical Supply, Inc. 17478-0715-10 5ML 2.06 0.41200 2018-01-01 - 2022-12-31 FSS
BRIMONIDINE TARTRATE 0.2% SOLN,OPH Golden State Medical Supply, Inc. 17478-0715-11 10ML 3.87 0.38700 2018-01-01 - 2022-12-31 FSS
BRIMONIDINE TARTRATE 0.2% SOLN,OPH Golden State Medical Supply, Inc. 17478-0715-12 15ML 4.25 0.28333 2018-01-01 - 2022-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Medtronic
Johnson and Johnson
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.